'Survival probability' presentation slideshows

Cognitive Economics

1.36k views • 108 slides

685 views • 41 slides

Characterization the W(Tungsten) stripping foil of Au +77 ions at g =10.5

N. Tsoupas. Characterization the W(Tungsten) stripping foil of Au +77 ions at g =10.5. What is the W stripping foil of the AtR Line? The stripping foil is made out of Tungsten material with dimensions 10[cm]x10[cm] and is 0.025 [mm] thick (48.3 m g/cm 2 ).

506 views • 40 slides

Lecture III p- Adic models of spectral diffusion and CO-rebinding

Introduction to Non-Archimedean Physics of Proteins. Lecture III p- Adic models of spectral diffusion and CO-rebinding Spectral diffusion in frozen proteins and first passage time distribution for ultrametric random walk.

570 views • 39 slides

Solar Neutrino Physics from SNO

493 views • 33 slides

The Borexino Solar Neutrino Experiment

1. The Borexino Solar Neutrino Experiment. Frank Calaprice for the Borexino Collaboration. Milano. Perugia. Borexino Collaboration. Princeton University. Genova. APC Paris. Virginia Tech. University. Univ. Massachusetts. Kurchatov Institute. Jagiellonian U. Cracow.

454 views • 26 slides

An Optimization Model that Links Masting to Seed Herbivory

306 views • 24 slides

Assessment of prediction error of risk prediction models

Assessment of prediction error of risk prediction models. Thomas Gerds and Martin Schumacher Institute of Medical Biometry and Medical Informatics University Hospital Freiburg, Germany. Outline. Situation Measures of prediction error Application to prediction of breast cancer survival

420 views • 24 slides

Survival analysis

475 views • 21 slides

Methods of Experimental Particle Physics

Methods of Experimental Particle Physics. Alexei Safonov Lecture #3. Calculations in HEP. Last time we wrote down Feynman rules for QED Today we will calculate the e+e - -> e+e - cross section Your homework would be to calculate ee ?ee scattering cross section

352 views • 18 slides

Theory

278 views • 18 slides

Theory

291 views • 17 slides

Long-term clinical outcome following emergency MR-based reperfusion therapy

Long-term clinical outcome following emergency MR-based reperfusion therapy for acute middle cerebral artery occlusion. Mori T, Nakazaki M, Tajiri H, Iwata T, Uesugi T, Soga N. Department of Stroke Treatment, Shonan Kamakura General Hospital Stroke Center, Kamakura City, Japan.

315 views • 17 slides

GI Neuroendocrine Tumors

Surgery for NE Tumors The University of Texas M. D. Anderson Cancer Center Houston, Texas Jason B. Fleming Carcinoid / Islet Cell. GI Neuroendocrine Tumors. Midgut Carcinoid Tumors Pancreatic Neuroendocrine Tumors. Biology of Tumor Detailed Knowledge of Pertinent Anatomy

687 views • 16 slides

Few Patients With Functional MR Are Treated Surgically: Duke Database Results

Few Patients With Functional MR Are Treated Surgically: Duke Database Results. Mitchell W. Krucoff MD FACC, FAHA, FSCAI Professor of Medicine / Cardiology Duke University Medical Center Director, Cardiovascular Devices Unit Duke Clinical Research Institute. Conflict of Interest.

256 views • 12 slides

Modeling the effect of many component mixtures on survival in time (RP 4.1)

Modeling the effect of many component mixtures on survival in time (RP 4.1). Jan Baas Vrije Universiteit Amsterdam dept. of Theoretical Biology In cooperation with: Mieke Broerse, Tjalling Jager, You Song, Kees van Gestel, Bas Kooijman. Approach.

211 views • 10 slides

The European Beewolves

The European Beewolves. Philanthus triangulum. Classification. Domain Eukaryote Kingdom Animalia Phylum Arthropoda Class Insecta Order Hymenoptera Family Crabronidae Subfamily Philanthinae Genus Philanthus Species P. triangulum. General info.

162 views • 6 slides

Carla van Tienen Medical Research Council carlavantienen@gmail

171 views • 6 slides

100

100. 90. 80. 70. 60. Survival probability without infliximab optimization (%). 50. 40. 30. 20. 10. 0. 0. 20. 40. 60. 80. Time (months). Number at risk. 80. 18. 8. 3. 1. Web Figure 1. Oussalah et al.

113 views • 1 slides

100

100. 90. 80. 70. 60. Survival probability without infliximab failure (%). 50. 40. 30. 20. 10. 0. 0. 20. 40. 60. 80. Time (months). Number at risk. 146. 45. 14. 6. 2. Web Figure 2. Oussalah et al.

121 views • 1 slides